How much profit has Zynex made this year?
Zynex has made -40.69 M USD this year.
Zynex Net Income 2025
Zynex Net Income
-40.69 M USD
Ticker
ZYXI
ISIN
US98986M1036
WKN
A0Q5XP
In 2025, Zynex's profit amounted to -40.69 M USD, a -1,459.15% increase from the 2.99 M USD profit recorded in the previous year.
The Zynex Net Income history
| YEAR | NET INCOME (M USD) |
|---|---|
| 2030e | 2.16 |
| 2029e | -4.02 |
| 2028e | -8.65 |
| 2027e | -5.72 |
| 2026e | -13.8 |
| 2025e | -40.69 |
| 2024 | 2.99 |
| 2023 | 9.73 |
| 2022 | 17 |
| 2021 | 17.1 |
| 2020 | 9.1 |
| 2019 | 9.5 |
| 2018 | 9.6 |
| 2017 | 7.4 |
| 2016 | 0.1 |
| 2015 | -2.9 |
| 2014 | -6.2 |
| 2013 | -7.3 |
| 2012 | 1.6 |
| 2011 | 1.6 |
| 2010 | 0.4 |
| 2009 | 2.4 |
| 2008 | 0.1 |
| 2007 | 2.1 |
| 2006 | -0.3 |
| 2005 | 0.3 |
Zynex Revenue, EBIT, Net Income
3 years
5 years
10 years
25 Years
Max
Loading chart...
Revenue
EBIT
Net Income
Details
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Zynex, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Zynex from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Zynex’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Zynex. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Zynex’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Zynex’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Zynex’s growth potential.
Zynex Revenue, EBIT and net profit per share
| Date | Zynex Revenue | Zynex EBIT | Zynex Net Income |
|---|---|---|---|
| 2030e | 148.51 M undefined | 0 undefined | 2.16 M undefined |
| 2029e | 135.86 M undefined | -714,000 undefined | -4.02 M undefined |
| 2028e | 124.13 M undefined | -7.75 M undefined | -8.65 M undefined |
| 2027e | 122.22 M undefined | -4.95 M undefined | -5.72 M undefined |
| 2026e | 103.5 M undefined | -16.98 M undefined | -13.8 M undefined |
| 2025e | 96.67 M undefined | -35.49 M undefined | -40.69 M undefined |
| 2024 | 192.35 M undefined | 5.99 M undefined | 2.99 M undefined |
| 2023 | 184.32 M undefined | 10.78 M undefined | 9.73 M undefined |
| 2022 | 158.2 M undefined | 22.9 M undefined | 17 M undefined |
| 2021 | 130.3 M undefined | 22.4 M undefined | 17.1 M undefined |
| 2020 | 80.1 M undefined | 10.3 M undefined | 9.1 M undefined |
| 2019 | 45.5 M undefined | 11.1 M undefined | 9.5 M undefined |
| 2018 | 31.9 M undefined | 10.4 M undefined | 9.6 M undefined |
| 2017 | 23.4 M undefined | 8.9 M undefined | 7.4 M undefined |
| 2016 | 13.3 M undefined | 600,000 undefined | 100,000 undefined |
| 2015 | 11.6 M undefined | -2.5 M undefined | -2.9 M undefined |
| 2014 | 11.1 M undefined | -7.9 M undefined | -6.2 M undefined |
| 2013 | 21.7 M undefined | -7.6 M undefined | -7.3 M undefined |
| 2012 | 39.7 M undefined | 2.7 M undefined | 1.6 M undefined |
| 2011 | 34.1 M undefined | 3.1 M undefined | 1.6 M undefined |
| 2010 | 24.1 M undefined | 1.6 M undefined | 400,000 undefined |
| 2009 | 18.7 M undefined | 3.8 M undefined | 2.4 M undefined |
| 2008 | 11.8 M undefined | 300,000 undefined | 100,000 undefined |
| 2007 | 8 M undefined | 3.2 M undefined | 2.1 M undefined |
| 2006 | 2.6 M undefined | -200,000 undefined | -300,000 undefined |
| 2005 | 2.1 M undefined | 200,000 undefined | 300,000 undefined |
Zynex stock margins
The Zynex margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Zynex. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Zynex.
3 years
5 years
10 years
25 Years
Max
Loading chart...
Gross margin
EBIT margin
Profit margin
Details
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Zynex's sales revenue. A higher gross margin percentage indicates that the Zynex retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Zynex's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Zynex's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Zynex's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Zynex. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Zynex's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Zynex Margin History
| Zynex Gross margin | Zynex Profit margin | Zynex EBIT margin | Zynex Profit margin |
|---|---|---|---|
| 2030e | 79.7 % | 0 % | 1.46 % |
| 2029e | 79.7 % | -0.53 % | -2.96 % |
| 2028e | 79.7 % | -6.25 % | -6.97 % |
| 2027e | 79.7 % | -4.05 % | -4.68 % |
| 2026e | 79.7 % | -16.41 % | -13.34 % |
| 2025e | 79.7 % | -36.71 % | -42.1 % |
| 2024 | 79.7 % | 3.11 % | 1.56 % |
| 2023 | 79.38 % | 5.85 % | 5.28 % |
| 2022 | 79.96 % | 14.48 % | 10.75 % |
| 2021 | 79.36 % | 17.19 % | 13.12 % |
| 2020 | 79.15 % | 12.86 % | 11.36 % |
| 2019 | 80.88 % | 24.4 % | 20.88 % |
| 2018 | 81.19 % | 32.6 % | 30.09 % |
| 2017 | 79.49 % | 38.03 % | 31.62 % |
| 2016 | 73.68 % | 4.51 % | 0.75 % |
| 2015 | 57.76 % | -21.55 % | -25 % |
| 2014 | 31.53 % | -71.17 % | -55.86 % |
| 2013 | 62.21 % | -35.02 % | -33.64 % |
| 2012 | 77.83 % | 6.8 % | 4.03 % |
| 2011 | 78.59 % | 9.09 % | 4.69 % |
| 2010 | 78.42 % | 6.64 % | 1.66 % |
| 2009 | 79.68 % | 20.32 % | 12.83 % |
| 2008 | 80.51 % | 2.54 % | 0.85 % |
| 2007 | 90 % | 40 % | 26.25 % |
| 2006 | 88.46 % | -7.69 % | -11.54 % |
| 2005 | 95.24 % | 9.52 % | 14.29 % |
Zynex Aktienanalyse
What does Zynex do?
Zynex Inc is an American company that manufactures and distributes medical devices and accessories. The company was founded in 1996 and is headquartered in Englewood, Colorado. In recent years, it has become a major player in the pain therapy market. The history of Zynex began with the development of a neurotherapeutic system called NeuroMove, which aimed to restore mobility in patients with paralysis after strokes or other neurological disorders. The company uses proprietary technology to provide safe and effective electrotherapeutic stimulation, which helps trigger muscle contractions and improve mobility. Over the years, the company has specialized in the development and sale of medical devices for pain therapy and rehabilitation. Zynex's products can be used in various areas, including electrostimulation, TENS and EMS therapy, home diagnostics, as well as blood pressure and oxygen measurement. Zynex offers devices specifically for pain therapy. These devices are used by many doctors and physiotherapists to support patients in their healing process. The company's flagship product is the Nexus D-11 EMS and TENS device, which is capable of conducting multiple pain treatments simultaneously. Another important device from Zynex is the InWave system, which applies FDA-approved electromagnetic wave therapy. The therapy is used for both acute and chronic pain and aims to promote the body's natural healing processes to relieve pain. Zynex also manufactures home diagnostic devices such as the blood sugar monitor and pulse oximeter, which can be regularly used by patients at home to monitor their well-being. These products help individuals develop an understanding of how their body responds to different treatments or environmental conditions. An important aspect of Zynex's business model is collaborating with healthcare customers. The company forms partnerships with medical facilities and practitioners to ensure that its products are effectively and safely utilized. These partnerships often include training programs to ensure that users of each device develop a basic understanding of how it works to ensure quality treatment. Zynex has also established a subsidiary called Zynex Medical Europe, which operates in European regions. The company is based in the Netherlands and is responsible for marketing and distributing Zynex's products in Europe. Overall, Zynex has established itself as a key player in the field of pain therapy and rehabilitation. Through its innovative technology and healthcare partnerships, the company is able to provide the best possible patient care. Zynex ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Zynex's Profit Margins
The profit margins of Zynex represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Zynex's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Zynex's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Zynex's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Zynex’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Zynex stock
How has the profit developed compared to last year?
The profit has increased by -1,459.15% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Zynex publish its earnings?
Zynex publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Zynex?
The profits of Zynex are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Zynex?
You can learn more about the earnings of Zynex by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Zynex pay?
Over the past 12 months, Zynex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zynex is expected to pay a dividend of -0.11 USD.
What is the dividend yield of Zynex?
The current dividend yield of Zynex is .
When does Zynex pay dividends?
Zynex pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Zynex?
Zynex paid dividends every year for the past 1 years.
What is the dividend of Zynex?
For the upcoming 12 months, dividends amounting to -0.11 USD are expected. This corresponds to a dividend yield of -9.32 %.
In which sector is Zynex located?
Zynex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zynex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zynex from 1/21/2022 amounting to 0.1 USD, you needed to have the stock in your portfolio before the ex-date on 1/5/2022.
When did Zynex pay the last dividend?
The last dividend was paid out on 1/21/2022.
What was the dividend of Zynex in the year 2024?
In the year 2024, Zynex distributed 0 USD as dividends.
In which currency does Zynex pay out the dividend?
The dividends of Zynex are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Zynex
Our stock analysis for Zynex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zynex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
